Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 1, 2014, Pages 38-47

  Wang, Ya ^a   Wang, Yuanmin ^b   Wang, Yiping ^a   Zheng, Guoping ^a   Tan, Thian Kui ^a   Lee, Sora ^a   Zhang, Jianlin ^a   Zhang, Geoff Yu ^b   Hu, Min ^a   Wang, Changqi ^a   Cao, Qi ^a   Zhao, Ye ^a   Wang, Xin Maggie ^c   Alexander, Stephen I ^a,b   Harris, David C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Adriamycin nephropathy; Antigen specificity; DO11.10 tregs

Indexed keywords

ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; OVALBUMIN;

ADRIAMYCIN NEPHROPATHY; ANIMAL; ANTIGEN SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; DISEASE MODEL; DO11.10 TREGS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NEPHRITIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

ADRIAMYCIN NEPHROPATHY; ANTIGEN SPECIFICITY; DO11.10 TREGS;

ANIMALS; ANTIGENS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEPHRITIS; OVALBUMIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 84891778337     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Balandina A, Lecart S, Dartevelle P, Saoudi A and Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735-741.
2. Viglietta V, Baecher-Allan C, Weiner HL and Hafler DA. Loss of functional suppression byCD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
3. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR and Lorenz HM. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004; 199: 1285-1291.
4. Sakaguchi S, Sakaguchi N, Asano M, Itoh M and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
5. Asano M, Toda M, Sakaguchi N and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184: 387-396.
6. Thornton AM and Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296.
7. Asseman C, Mauze S, Leach MW, Coffman RL and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
8. Seddon B and Mason D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes. J Exp Med 1999; 189: 279-288.
9. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L and Singer A. Basis of CTLA-4 function in regulatory and conventional CD4+ T cells. Blood 2012; 119: 5155-63.
10. Salcido-Ochoa F, Tsang J, Tam P, Falk K and Rotzschke O. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? Transplant Rev (Orlando) 2010; 24: 52-66.
11. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Hopner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rotzschke O and Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225-1232.
12. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F and Sakaguchi S. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as akey function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162: 5317-5326.
13. Sather BD, Treuting P, Perdue N, Miazgowicz M, Fontenot JD, Rudensky AY and Campbell DJ. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 2007; 204: 1335-1347.
14. Campbell DJ and Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011; 11: 119-130.
15. Seddon B and Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 1999; 189: 877-882.
16. Taguchi O, Kontani K, Ikeda H, Kezuka T, Takeuchi M and Takahashi T. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 1994; 82: 365-369.
17. Samy ET, Parker LA, Sharp CP and Tung KS. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med 2005; 202: 771-781.
18. Lathrop SK, Santacruz NA, Pham D, Luo J and Hsieh CS. Antigen-specific peripheral shaping of the natural regulatory T cell population. J Exp Med 2008; 205: 3105-3117.
19. Koenen HJ and Joosten I. Antigen-specific regulatory T-cell subsets in transplantation tolerance regulatory T-cell subset quality reduces the need for quantity. Hum Immunol 2006; 67: 665-675.
20. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL and Cohen JL. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003; 112: 1688-1696.
21. Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H and Bluestone JA. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005; 175: 3053-3059.
22. Masteller EL, Tang Q and Bluestone JA. Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential. Semin Immunol 2006; 18: 103-110.
23. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M and Bluestone JA. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465.
24. Tarbell KV, Yamazaki S, Olson K, Toy P and Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199: 1467-1477.
25. Thornton AM and Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183-190.
26. Robertson JM, Jensen PE and Evavold BD. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J Immunol 2000; 164: 4706-4712.
27. Murphy KM, Heimberger AB and Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990; 250: 1720-1723.
28. Mahajan D, Wang Y, Qin X, Zheng G, Wang YM, Alexander SI and Harris DC. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 2006; 17: 2731-2741.
29. Wang YM, Zhang GY, Wang Y, Hu M, Wu H, Watson D, Hori S, Alexander IE, Harris DC and Alexander SI. Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J Am Soc Nephrol 2006; 17: 697-706.
30. Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E and Rosenkranz AR. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 2005; 16: 1360-1370.
31. Mason PD and Pusey CD. Glomerulonephritis: diagnosis and treatment. BMJ 1994; 309: 1557-1563.
32. Wang Y, Wang YP, Tay YC and Harris DC. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 2000; 58: 1797-1804.
33. Wu H, Wang Y, Tay YC, Zheng G, Zhang C, Alexander SI and Harris DC. DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy. Kidney Int 2005; 67: 2178-2186.
34. Zheng G, Wang Y, Xiang SH, Tay YC, Wu H, Watson D, Coombes J, Rangan GK, Alexander SI and Harris DC. DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury. J Am Soc Nephrol 2006; 17: 465-474.
35. Thorstenson KM and Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167: 188-195.
36. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Zeitz M and Duchmann R. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005; 128: 1868-1878.
37. Wei S, Kryczek I and Zou W. Regulatory T-cell compartmentalization and trafficking. Blood 2006; 108: 426-431.
38. Nortier JL, Debiec H, Tournay Y, Mougenot B, Noel JC, Deschodt-Lanckman MM, Janssen F and Ronco P. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring. Pediatr Nephrol 2006; 21: 1399-1405.
39. Debiec H and Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
40. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB and Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.